等待開盤 07-22 09:30:00 美东时间
-0.250
-0.87%
多家机构首予Amrize买入评级,目标价53~62美元;HC Wainwright & Co.上调内克塔治疗目标价至120美元,维持"买入"评级>>
06-25 08:39
Oppenheimer analyst Brian Schwartz maintains Braze (NASDAQ:BRZE) with a Outperform and lowers the price target from $44 to $38.
06-24 22:00
Oppenheimer analyst Brian Schwartz reiterated a Buy rating on Braze (BRZE – Res...
06-24 18:55
<span> <meta content="no-referrer" name="referrer"></span><span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote> <p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• **财务业绩**: - Braze在2026财年第一季度实现营收1.621亿美元,同比增长20%。 - 非GAAP毛利润为1.12亿美元,毛利率为69.3%,高于去年同期的67.9%。 - 非GAAP运营收入为300万美元,占营收的2%,而去年同期为亏损1000万美元(负7%利润率)。 - 非GAAP净利润为700万美元,每股收益0.07美元,而去年同期为净亏损600万美元,每股亏损0.05美元。 - 自由现金流为2300万美元,高于
06-07 12:05
“英伟达概念股”Applied Digital股价一周翻倍!Circle上市连续两日飙涨;SpaceX对手ASTS周内大涨35%>>
06-07 11:31
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1138028221594226688.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital:维持Aemetis(AMTX)"买入"评级,目标价从19美元升至20美元</p> <p>• Ascendiant Capital:维持Lucid Diagnostics(LUCD)"买
06-07 08:37
Braze (NASDAQ:BRZE) was down during early trading Friday, following its first quarter fiscal 2026 results, but analysts remain optimistic as revenue growth is likely to accelerate in the quarters ahea...
06-06 21:07
Braze, Inc. ( ($BRZE) ) has released its Q1 earnings. Here is a breakdown of th...
06-06 11:55
Braze (NASDAQ:BRZE) lowers FY2026 Adj EPS guidance from $0.31-$0.35 to $0.15-$0.18 vs $0.34 analyst estimate. Raises FY2026 sales outlook from $686.00 million-$691.00 million to $702.00 million-$706.00 million vs $690.20
06-06 04:13
Companies Reporting Before The Bell • Hello Gr (NASDAQ:MOMO) is expected to rep...
06-05 16:32